AP-1 as a regulator of cell life and death

Nature Cell Biology

Volumn 4, Issue 5, 2002, Pages E131-E136

  Shaulian, Eitan ^a   Karin, Michael ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE IDENTIFICATION; GENE REPRESSION; GENE TARGETING; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 0036098552     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb0502-e131     Document Type: Review

References (98)

1. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
2. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity
3. cJun, JunB, and JunD differ in their binding affinities to the AP-1 and CRE consensus sequences: Effect of Fos proteins
4. JunB inhibits and cFos stimulates the transforming and transactivating activities of cJun
5. JunB differs in its biological properties from, and is a negative regulator of c-Jun
6. The regulation of AP-1 activity by mitogen-activated protein kinases
7. AP-1 function and regulation
8. Control of cell cycle progression by c-Jun is p53 dependent
9. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression
10. The mammalian UV response: C-Jun induction is required for exit from p53-imposed growth arrest
11. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity
12. Promoter-specific trans-activation and inhibition mediated by JunB
13. Mammalian MAP kinase signalling cascades
14. Serum-regulated transcription by serum response factor (Srf) - A novel role for the DNA binding domain
15. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity
16. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C
17. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation
18. Transcription factor ATF2: Regulation by the JNK signal transduction pathway
19. Rapid and preferential activation of the c-jun gene during the mammalian UV response
20. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters
21. Identification of an oncoprotein-responsive and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
22. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
23. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
24. AP-1 in cell proliferation and survival
25. The jun and fos protein families are both required for cell cycle progression in fibroblasts
26. Fos family members induce cell cycle entry by activating cyclin D1
27. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos
28. Targeted disruption of the murine junD gene results in multiple defects in male reproductive function
29. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
30. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture
31. Functions of c-jun in liver and heart development
32. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin
33. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms
34. p21 is a universal inhibitor of cyclin kinases
35. WAF1, a potential mediator of p53 tumor suppression
36. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity
37. Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes
38. Deregulated expression of human (Ic-jun) transforms primary rat embryo cells in cooperation with and activated c-Ha-(Iras) gene and transforms Rat-la cells as a single gene
39. JunB is essential for mammalian placentation
40. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression
41. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage
42. JunB can substitute for c-Jun in mouse development and cell proliferation
43. JunD protects cells from p53-dependent senescence and apoptosis
44. Tumor surveillance via the ARF-p53 pathway
45. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription
46. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras
47. Avian sarcoma cirus 17 carries the Jun oncogene
48. Complete nucleotide sequence of a human c-onc gene: Deduced amino acid sequence of the human c-fos protein
49. Stepwise transformation of rat embryo fibroblasts: C-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization
50. Cellular transformation and malignancy induced by ras require c-jun
51. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
52. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis
53. Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation
54. cFos can induce cellular transformation: Novel mechanism of activating a cellular oncogene
55. Transformation by ras modifies AP1 composition and activity
56. Role of DNA 5-methylcytosine transferase in cell transformation by fos
57. Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression
58. Autocrine growth and anchorage independence: Two complementing Jun-controlled genetic programs of cellular transformation
59. Deregulated c-fos expression interferes with normal bone development in transgenic mice
60. c-fos expression induces bone tumors in transgenic mice
61. c-fos is required for malignant progression of skin tumors
62. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
63. AP-1 in mouse development and tumorigenesis
64. c-Fos expression procedes programmed cell death in vivo
65. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells
66. Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland
67. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis
68. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death
69. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines
70. Mitogen-activated protein kinase cascades as regulators of stress responses
71. Induction of apoptosis by the transcription factor c-Jun
72. Induction of apoptosis by c-Fos protein
73. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
74. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
75. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release
76. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo
77. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release
78. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
79. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
80. Inhibition of JNK activation through NF-κB target genes
81. Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli
82. Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia in vivo
83. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury
84. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
85. c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents
86. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
87. Cooperation between STAT3 and c-jun suppresses Fas transcription
88. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
89. p53-mediated protective responses to UV irradiation
90. p21-induced cycle arrest in G(1) protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage
91. Resistance of senescent keratinocytes to UV-induced apoptosis
92. c-jun is essential for normal mouse development and hepatogenesis
93. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development
94. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death
95. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
96. Stress-signaling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3
97. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors